Drugs / Ozonated olive oil
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT06990282 | Jul 2025 → Feb 2026 overdue | gingivitis, periodontitis | Fayoum University | Not yet recruiting | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT05594472 | Nov 2022 → Apr 2023 | bullous pemphigoid, pemphigus vulgaris | Cairo University | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ozonated olive oil | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06990282 ↗ |
| Route | Topical | “ozonated oil will be applied to on one lesion followed by gauze for 5 consecutive days.” NCT05594472 ↗ |